• LAST PRICE
    15.6950
  • TODAY'S CHANGE (%)
    Trending Down-0.3050 (-1.9063%)
  • Bid / Lots
    15.6900/ 1
  • Ask / Lots
    15.7300/ 4
  • Open / Previous Close
    16.0000 / 16.0000
  • Day Range
    Low 15.6200
    High 16.1500
  • 52 Week Range
    Low 9.5000
    High 19.0900
  • Volume
    336,870
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 16
TimeVolumeAVDL
09:32 ET1879315.81
09:34 ET270016
09:36 ET333815.94
09:38 ET40016
09:39 ET140016
09:41 ET10016
09:43 ET45015.94
09:45 ET80015.94
09:48 ET30015.935
09:52 ET235215.96
09:54 ET98015.98
09:56 ET282415.98
09:57 ET3690116
09:59 ET14323216
10:01 ET364016.045
10:03 ET370016.03
10:06 ET234216.065
10:08 ET10016.1
10:10 ET100216.09
10:12 ET252716.07
10:14 ET61616.065
10:15 ET1411616.135
10:17 ET226216.135
10:19 ET661116.125
10:21 ET135916.1399
10:24 ET270016.11
10:26 ET50016.125
10:28 ET92716.14
10:30 ET276816.12
10:32 ET70016.1
10:33 ET453815.94
10:35 ET126715.94
10:37 ET197615.86
10:39 ET199815.78
10:42 ET907015.89
10:44 ET82015.88
10:46 ET30015.88
10:48 ET20615.9
10:50 ET25715.88
10:51 ET368315.72
10:53 ET52115.68
10:55 ET107015.7
10:57 ET80015.64
11:00 ET40415.645
11:02 ET210215.65
11:04 ET615315.67
11:06 ET165515.695
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAVDL
Avadel Pharmaceuticals PLC
1.5B
-8.4x
---
United StatesTARS
Tarsus Pharmaceuticals Inc
1.4B
-8.0x
---
United StatesLQDA
Liquidia Corp
1.0B
-8.5x
---
United StatesLGND
Ligand Pharmaceuticals Inc
1.6B
16.7x
-12.71%
United StatesPBAJ
Petro USA Inc
1.0B
-31,250.0x
---
United StatesOCUL
Ocular Therapeutix Inc
944.8M
-5.7x
---
As of 2024-05-22

Company Information

Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's lead product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and MEDUSA. Its MICROPUMP technology allows for the development of modified release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.

Contact Information

Headquarters
Block 10-1 Blanchardstown Corporate Park BallycoolinDUBLIN, Ireland 15
Phone
---
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Geoffrey Glass
Chief Executive Officer, Director
Gregory Divis
Chief Financial Officer
Thomas McHugh
Chief Commercial Officer
Richard Kim
Independent Director
Eric Ende

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$55.1M
Shares Outstanding
96.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.73
EPS
$-1.86
Book Value
$0.98
P/E Ratio
-8.4x
Price/Sales (TTM)
27.9
Price/Cash Flow (TTM)
---
Operating Margin
-269.70%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.